1. Zhang TD, Li YS. Clinical analysis and empirical study on treatment of Ailing No. 1 in 62 cases of acute promyelocytic leukemia. J Integr Tradit West Med (Chin) 1984;4:19.
2. Chen G Q, Zhu J, Shi XG, Ni JH, Zhong HJ, Si GY, et al. In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with down regulation of Bcl-2 expression and modulation of PML-RARα/PML proteins. Blood 1996;88:1052–1061.
3. Zhang P. The use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia. J Leukemia (Chin) 1999;8:195–196.
4. Zhang P. The use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia. J Biol Regul Homeost Agents 1999;13:195–200.
5. Zhang P, Wang SY, Hu LH, Qiu FQ, Yang HF, Xiao YJ, et al. Seven years’ summary report on the treatment of acute promyelocytic leukemia with arsenic trioxide—analysis of 242 cases. J Clin Hematol (Chin) 2000;21:67–70.